- Supported exchanges /
- TA /
- MCTC.TA
Nextage Therapeutics Ltd (MCTC TA) stock market data APIs
Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. It offers CellDetect, a diagnostic platform for early cancer detection, including bladder cancer, cervical cancer, and prostate cancer. The company also provides BRONJ Test, a test for bisphosphonate-related osteonecrosis of the jaw. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. Nextage Therapeutics Ltd is based in Tel Aviv, Israel.
Nextage Therapeutics Ltd Financial Data Overview
71.9 | |
70.1 | |
- | |
71.9 | |
66.2 | |
28-96 | |
9 537 K | |
2 271 K | |
336 K | |
0 | |
1.0529 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Nextage Therapeutics Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 336 K
- EBITDA -5 381 000
- Earnings Per Share -0.244
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Nextage Therapeutics Ltd Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Nextage Therapeutics Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: